Plant-based start-up Meala FoodTech has partnered with DSM-Firmenich to launch Vertis PB Pea, a texturizing Through Meala’s partnership with DSM-Firmenich, the solution is now available to customers in Europe. Razmovich, CEO and co-founder of Meala FoodTech, commented: “We’re looking forward to working with DSM-Firmenich

The recipe for success DSM-Firmenich has the ingredients, technology and formulation expertise to help this conversation will be Francesc Puerto, technical sales manager in Europe for sugar reduction, at DSM-Firmenich

DSM-Firmenich has unveiled Maxilact Next, which the company says is “the fastest pure lactase available Rodolfo Garza, global business development manager of milk and plant-based alternatives at DSM-Firmenich DSM-Firmenich says that 70% of consumers worldwide are unable to properly digest lactose and that its

DSM-Firmenich has agreed to sell its Animal Nutrition & Health (ANH) business to private equity firm The deal, which includes a potential earnout of up to €0.5 billion, will see DSM-Firmenich retain a 20% The transaction marks the final step in DSM-Firmenich’s exit from animal nutrition following the €1.5 DSM-Firmenich said it will enter into a long-term vitamins supply agreement with the Essential Products DSM-Firmenich says the divestment will result in a non-cash impairment charge of around €1.9 billion

DSM-Firmenich has announced the completion of the sale of its 100% equity interest in DSM Jiangshan Pharmaceutical In June 2023, DSM-Firmenich announced a restructuring of its vitamin assets aimed at significant cost

DSM-Firmenich has announced new research that could change how the food industry manages one of its biggest DSM-Firmenich says the research provides the scientific foundation to design more robust culture blends Noël van Peij, co-author and principal scientist at DSM-Firmenich, added: “By decoding the complex relationship Evandro Oliveira de Souza, global senior vice-president cheese business unit at DSM-Firmenich, commented DSM-Firmenich said it plans to integrate the findings into future product development to support producers

DSM-Firmenich has finalised the sale of its MEG-3 fish oil business to KD Pharma Group. While the financial specifics of the deal remain undisclosed, DSM-Firmenich has acquired a minority stake This divestiture aligns with DSM-Firmenich's broader strategy to streamline its operations and focus #DSM #dsmfirmenich #fishoil #omega3 #acquistion

DSM-Firmenich has received approval for four more human milk oligosaccharide (HMO) ingredients to be The approval was obtained through the company's HMO supplier, Glycom A/S, following DSM-Firmenich's application It marks DSM-Firmenich as the first HMO manufacturer to apply for and secure approval for these four Christoph Röhrig, head of HMO Regulatory at DSM-Firmenich, commented: “DSM-Firmenich is passionately Maryse Darch, regulatory and scientific affairs manager at DSM-Firmenich, added: “Australia and New Zealand

DSM-Firmenich has announced the sale of its MEG-3 fish oil business to KD Pharma Group, a contract development As part of the transaction, DSM-Firmenich will obtain a minority stake of 29% in KD Pharma's parent company The move comes as DSM-Firmenich aims to focus its lipids activities on its unique algae-based Omega-3 review, we decided to de-prioritise certain business segments, including the MEG-3 business," said a DSM-Firmenich The transaction includes DSM-Firmenich's MEG-3 business for the food and beverage, dietary supplement

DSM-Firmenich has launched the sale of up to 6.7 million existing ordinary shares through an accelerated The news follows the completion of the merger between DSM and Firmenich at the start of the month. following the sale of its ordinary shares to institutional investors, representing approximately 2.5% of DSM-Firmenich's According to a statement, DSM-Firmenich intends to use the net proceeds of the Share Placement to "fund the buy-out procedure in accordance with Dutch law that the company commenced in order to acquire the DSM

For a start, it’s created via a patented DSM-Firmenich process that extracts the leftover protein-rich CanolaPRO provides appetising texture and high nutrition – to the point where the professional Team DSM-Firmenich CanolaPRO is just one of many nutritious, delicious, sustainable and label-friendly solutions from DSM-Firmenich

In this podcast with FoodBev's Siân Yates, Martin Mei, DSM-Firmenich’s global head of health benefits Martin discusses DSM-Firmenich’s role in addressing widespread vitamin and mineral deficiencies worldwide The podcast features key solutions such as DSM-Firmenich’s life’s Omega range and its award-winning Vertis #DSMFirmenich #DSM #podcast #health #nutrition